378 related articles for article (PubMed ID: 12975457)
21. An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice.
Roychowdhury S; McMullen MR; Pritchard MT; Hise AG; van Rooijen N; Medof ME; Stavitsky AB; Nagy LE
Hepatology; 2009 Apr; 49(4):1326-34. PubMed ID: 19133650
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
[TBL] [Abstract][Full Text] [Related]
23. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
24. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
25. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.
Yamada Y; Kirillova I; Peschon JJ; Fausto N
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1441-6. PubMed ID: 9037072
[TBL] [Abstract][Full Text] [Related]
26. Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat.
Daveau M; Benard M; Scotte M; Schouft MT; Hiron M; Francois A; Salier JP; Fontaine M
J Immunol; 2004 Sep; 173(5):3418-24. PubMed ID: 15322206
[TBL] [Abstract][Full Text] [Related]
27. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury.
Markiewski MM; Mastellos D; Tudoran R; DeAngelis RA; Strey CW; Franchini S; Wetsel RA; Erdei A; Lambris JD
J Immunol; 2004 Jul; 173(2):747-54. PubMed ID: 15240660
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice.
Kuboki S; Shin T; Huber N; Eismann T; Galloway E; Schuster R; Blanchard J; Edwards MJ; Lentsch AB
Hepatology; 2008 Oct; 48(4):1213-23. PubMed ID: 18688883
[TBL] [Abstract][Full Text] [Related]
29. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin.
Kirchhoff K; Weinmann O; Zwirner J; Begemann G; Götze O; Kapp A; Werfel T
Immunology; 2001 Jun; 103(2):210-7. PubMed ID: 11412308
[TBL] [Abstract][Full Text] [Related]
30. The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury.
Sakuma M; Morooka T; Wang Y; Shi C; Croce K; Gao H; Strainic M; Medof ME; Simon DI
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1196-202. PubMed ID: 20299685
[TBL] [Abstract][Full Text] [Related]
31. Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.
Strainic MG; Shevach EM; An F; Lin F; Medof ME
Nat Immunol; 2013 Feb; 14(2):162-71. PubMed ID: 23263555
[TBL] [Abstract][Full Text] [Related]
32. Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β.
Ignatius A; Schoengraf P; Kreja L; Liedert A; Recknagel S; Kandert S; Brenner RE; Schneider M; Lambris JD; Huber-Lang M
J Cell Biochem; 2011 Sep; 112(9):2594-605. PubMed ID: 21598302
[TBL] [Abstract][Full Text] [Related]
33. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
34. The regulation of liver cell survival by complement.
Markiewski MM; DeAngelis RA; Strey CW; Foukas PG; Gerard C; Gerard N; Wetsel RA; Lambris JD
J Immunol; 2009 May; 182(9):5412-8. PubMed ID: 19380788
[TBL] [Abstract][Full Text] [Related]
35. C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection.
Kacani L; Bánki Z; Zwirner J; Schennach H; Bajtay Z; Erdei A; Stoiber H; Dierich MP
J Immunol; 2001 Mar; 166(5):3410-5. PubMed ID: 11207298
[TBL] [Abstract][Full Text] [Related]
36. Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A.
Chen L; Zeng Y; Yang H; Lee TD; French SW; Corrales FJ; García-Trevijano ER; Avila MA; Mato JM; Lu SC
FASEB J; 2004 May; 18(7):914-6. PubMed ID: 15033934
[TBL] [Abstract][Full Text] [Related]
37. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
[TBL] [Abstract][Full Text] [Related]
38. The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation.
Kastl SP; Speidl WS; Kaun C; Rega G; Assadian A; Weiss TW; Valent P; Hagmueller GW; Maurer G; Huber K; Wojta J
J Thromb Haemost; 2006 Aug; 4(8):1790-7. PubMed ID: 16879222
[TBL] [Abstract][Full Text] [Related]
39. Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a.
Li K; Fazekasova H; Wang N; Peng Q; Sacks SH; Lombardi G; Zhou W
Immunobiology; 2012 Jan; 217(1):65-73. PubMed ID: 21855168
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration.
Wuestefeld T; Klein C; Streetz KL; Betz U; Lauber J; Buer J; Manns MP; Müller W; Trautwein C
J Biol Chem; 2003 Mar; 278(13):11281-8. PubMed ID: 12509437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
